Interactions between VWF and FVIII in the circulation prevent proteolysis of FVIII [19], and pre-incubation of rVWF with rFVIII in vitro might be expected to stabilize FVIII:C prior to administration of the combined therapeutic product in patients with VWD. The gene discussed is F8; the disease is von Willebrand disease (hereditary or acquired).